Delivery Order SPE2DB20D2014-SPE2DB24FD10D

Award Date 9/20/24
Potential Completion Date 9/23/24
Potential Value $4.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,699.40 firm-fixed-price delivery order is for 4,566,716,754 units of Alfuzosin HCl ER 10 mg tablets, with a completion date of December 16, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,000.33 firm fixed-price delivery order is for the delivery of Alfuzosin HCL ER 10 mg tablets to support military healthcare programs. The contract has an ultimate completion date of July 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $25,460.19 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Alfuzosin HCL ER 10 mg tablets and is not set aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle...
This is a $11,307.61 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Alfuzosin HCL ER 10 mg tablets. The award is not a set-aside contract. This delivery order appears to be part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Alfuzosin HCL ER 10 mg tablets. The contract is a firm fixed price, non-set-aside award with a ceiling value of $1,466.08 and a performance period ending on April 29, 2025. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,398.26, is for the delivery of Alfuzosin HCL ER 10 mg tablets over a period ending on October 20, 2023. This is a firm fixed-price delivery order contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This contract award for $1,415.85 was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Alfuzosin HCL ER 10 mg tablets and has an ultimate completion date of October 13, 2023. The contract is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,644.03, is for the delivery of Alfuzosin HCL ER 10 mg tablets. This is a firm fixed price delivery order contract with an ultimate completion date of January 27, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Alfuzosin HCL ER 10 mg tablets. The contract has a ceiling value of $5,641.47 and a period of performance through December 2023. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
The Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order valued at $2,506.72 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 120 tablets of Alfuzosin HCl ER 10 mg. This award is under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and is in effect through December 2025. The contract does not have a set-aside designation and is intended to support military...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FD10D
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the provision of Alfuzosin HCL ER 10 mg tablets. The delivery order, valued at $4,537.55, was issued under an Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999 through December 2025, enables the DLA to efficiently procure a comprehensive range of medical commodities, including pharmaceuticals, to support military treatment programs and facilities worldwide. This delivery order does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by defense and civilian agencies to supply essential medical products and supplies.

Generated 12/20/24, 9:36 AM